Manasi Jaiman serves as Chief Medical Officer at Aardvark Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Manasi Jaiman has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 9, 2026 involved receiving (via award) 70,549 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | AARD | $0 | Award | 70,549 | $N/A | Discretionary |
Manasi Jaiman currently holds 70,549 shares of Aardvark Therapeutics, Inc. (AARD), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, Manasi Jaiman has been a net neutral trader of AARD stock. They have purchased $0 and sold $0 worth of shares.
Manasi Jaiman's most recent insider trade was on Feb 9, 2026, when they sold 70,549 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted